WEBSITE BSE:533259 NSE : SASTASUNDR 10 May, 16:01
Market Cap ₹929 Cr.
Stock P/E -22.3
P/B 1.2
Current Price ₹292.1
Book Value ₹ 241
Face Value 10
52W High ₹506.4
Dividend Yield 0%
52W Low ₹ 236.1
Sastasundar Ventures Ltd, formerly Microsec Financial Services Ltd, is engaged in constructing digital community of healthcare managing efficient pharma supply chain and connecting doctors, diagnostic offerings, healthcare clinics and health records offerings. Its network is designed to provide custom designed health conditioned merchandise, home delivery of wellness products, healthcare data offerings, connecting medical doctors for appointment and consultation through virtual media, and different offerings. Its business verticals encompass technology carrier company, medicines and wellbeing products distribution, purchaser engagement offerings, and captive distribution network of healthbudies. Its brands encompass DNAVITA, CHEFON, PURE & FRESH SPICES, PURE & FRESH TEA, ZEROTOX, Authentic Herbal, and NOKNOK. Its Healthbuddy Honest Organic provides organic produces that includes flax seed, fenugreek, rice, and green tea,. It has a Website and cellular App named Sastasundar.Com.
Price goes above X
Price falls below X
PE goes above X
PE falls below X
₹ | |
#(Fig in Cr.) | Sep 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
---|---|---|---|---|---|---|---|---|---|---|
Operating Revenue | 159 | 143 | 157 | 192 | 254 | 281 | 313 | 336 | 358 | 374 |
Other Income | 4 | 3 | 4 | 5 | 6 | 4 | 9 | 12 | 10 | 20 |
Total Income | 163 | 145 | 161 | 197 | 260 | 285 | 322 | 348 | 368 | 395 |
Total Expenditure | 169 | 156 | 177 | 208 | 261 | 291 | 324 | 327 | 355 | 371 |
Operating Profit | -6 | -11 | -16 | -11 | -1 | -6 | -2 | 21 | 13 | 24 |
Interest Expense | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Depreciation | 1 | 1 | 1 | 1 | 2 | 2 | 3 | 2 | 2 | 2 |
Profit Before Tax | -8 | 1157 | -29 | -12 | -11 | -9 | -6 | 19 | 11 | 21 |
Provision for Tax | 1 | 133 | -8 | -4 | -29 | -6 | 16 | -5 | -2 | 1 |
Profit After Tax | -9 | 1024 | -21 | -8 | 18 | -3 | -22 | 25 | 13 | 20 |
Adjustments | 4 | -285 | 1 | -9 | -19 | -17 | -12 | -23 | -21 | -21 |
Profit After Adjustments | -5 | 739 | -19 | -18 | -1 | -19 | -34 | 1 | -8 | -1 |
Adjusted Earnings Per Share | -1.4 | 232.3 | -6.1 | -5.6 | -0.4 | -6 | -10.8 | 0.4 | -2.6 | -0.2 |
#(Fig in Cr.) | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | TTM |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Revenue | 45 | 27 | 48 | 86 | 133 | 159 | 220 | 385 | 548 | 631 | 1040 | 1381 |
Other Income | 3 | 4 | 4 | 3 | 4 | 3 | 2 | 3 | 3 | 12 | 24 | 51 |
Total Income | 48 | 31 | 52 | 89 | 137 | 162 | 222 | 389 | 552 | 643 | 1063 | 1433 |
Total Expenditure | 32 | 35 | 62 | 117 | 155 | 174 | 255 | 440 | 561 | 678 | 1083 | 1377 |
Operating Profit | 16 | -4 | -10 | -28 | -18 | -12 | -33 | -51 | -9 | -35 | -19 | 56 |
Interest Expense | 1 | 1 | 1 | 1 | 3 | 1 | 3 | 1 | 3 | 3 | 2 | 0 |
Depreciation | 2 | 2 | 6 | 7 | 7 | 6 | 6 | 5 | 4 | 4 | 8 | 9 |
Profit Before Tax | 13 | -7 | -15 | -37 | -28 | -12 | -42 | -58 | -16 | 1109 | -122 | 45 |
Provision for Tax | 4 | -0 | -0 | -0 | 1 | 2 | 1 | -5 | 1 | 244 | -23 | 10 |
Profit After Tax | 9 | -6 | -15 | -37 | -29 | -15 | -43 | -52 | -17 | 865 | -99 | 36 |
Adjustments | -1 | -0 | -0 | -0 | -0 | 3 | 5 | 13 | 7 | -238 | 27 | -77 |
Profit After Adjustments | 8 | -6 | -15 | -37 | -29 | -12 | -38 | -39 | -10 | 627 | -72 | -42 |
Adjusted Earnings Per Share | 2.6 | -2 | -4.7 | -11.5 | -9 | -3.7 | -11.8 | -12.2 | -3.3 | 197 | -22.7 | -13.2 |
# | 1 Year | 3 Year | 5 Year | 10 Year |
---|---|---|---|---|
Sales CAGR | 65% | 39% | 46% | 37% |
Operating Profit CAGR | 0% | 0% | 0% | NAN% |
PAT CAGR | -111% | 0% | 0% | NAN% |
# | 1 Year | 3 Year | 5 Year | 10 Year |
---|---|---|---|---|
Share Price CAGR | 23% | 16% | 20% | 23% |
ROE Average | -13% | 50% | 18% | 4% |
ROCE Average | -15% | 64% | 28% | 10% |
#(Fig in Cr.) | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
---|---|---|---|---|---|---|---|---|---|---|---|
Shareholder's Funds | 276 | 270 | 255 | 218 | 195 | 175 | 143 | 210 | 200 | 827 | 753 |
Minority's Interest | 0 | 0 | 0 | 0 | 0 | 28 | 58 | 36 | 29 | 268 | 240 |
Borrowings | 0 | 0 | 0 | 2 | 2 | 0 | 0 | 0 | 0 | 0 | 0 |
Current Liability | 51 | 52 | 33 | 31 | 49 | 29 | 25 | 69 | 63 | 70 | 120 |
Other Liabilities & Provisions | 9 | 11 | 13 | 13 | 10 | 6 | 6 | 0 | 0 | 114 | 91 |
Total Liabilities | 337 | 333 | 301 | 265 | 256 | 238 | 232 | 316 | 293 | 1278 | 1204 |
Loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments | 21 | 18 | 18 | 9 | 9 | 18 | 22 | 41 | 30 | 513 | 443 |
Fixed Assets | 94 | 117 | 137 | 126 | 125 | 117 | 116 | 114 | 110 | 93 | 104 |
Other Loans | 30 | 35 | 23 | 22 | 13 | 5 | 10 | 10 | 6 | 11 | 15 |
Other Non Current Assets | 18 | 9 | 23 | 19 | 1 | 1 | 1 | 0 | 0 | 120 | 98 |
Current Assets | 173 | 154 | 100 | 89 | 108 | 97 | 83 | 151 | 146 | 540 | 541 |
Total Assets | 337 | 333 | 301 | 265 | 256 | 238 | 232 | 316 | 293 | 1278 | 1204 |
#(Fig in Cr.) | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
---|---|---|---|---|---|---|---|---|---|---|---|
Opening Cash & Cash Equivalents | 6 | 17 | 8 | 7 | 7 | 14 | 12 | 6 | 17 | 12 | 13 |
Cash Flow from Operating Activities | 38 | 36 | -12 | -12 | -2 | -49 | -30 | -69 | -31 | -207 | -104 |
Cash Flow from Investing Activities | -8 | -42 | 7 | -1 | 4 | 21 | -2 | -22 | 21 | 220 | 124 |
Cash Flow from Financing Activities | -19 | -3 | 4 | 13 | 5 | 33 | 26 | 103 | 4 | -11 | -1 |
Net Cash Inflow / Outflow | 11 | -10 | -1 | -0 | 7 | 5 | -6 | 11 | -5 | 1 | 19 |
Closing Cash & Cash Equivalent | 17 | 8 | 7 | 7 | 14 | 12 | 6 | 17 | 12 | 13 | 32 |
# | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
---|---|---|---|---|---|---|---|---|---|---|---|
Earnings Per Share (Rs) | 2.58 | -2.04 | -4.69 | -11.51 | -9 | -3.73 | -11.81 | -12.2 | -3.27 | 197.04 | -22.7 |
CEPS(Rs) | 3.3 | -1.4 | -2.87 | -9.2 | -6.81 | -2.89 | -11.6 | -14.85 | -3.97 | 273.26 | -28.69 |
DPS(Rs) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Book NAV/Share(Rs) | 86.91 | 84.87 | 80.05 | 68.52 | 59.6 | 55.15 | 43.23 | 64.48 | 61.27 | 258.25 | 235.27 |
Net Profit Margin | 19.49 | -23.71 | -30.66 | -42.39 | -21.5 | -9.24 | -19.51 | -13.53 | -3.12 | 137.01 | -9.57 |
Operating Margin | 30.65 | -22.53 | -28.66 | -41.11 | -18.84 | -7.23 | -17.64 | -14.56 | -2.51 | 176.24 | -11.57 |
PBT Margin | 28.08 | -25.05 | -30.72 | -42.71 | -21.04 | -7.76 | -19 | -14.94 | -2.99 | 175.71 | -11.76 |
ROA(%) | 2.63 | -1.89 | -4.68 | -12.92 | -10.97 | -5.96 | -18.25 | -19.05 | -5.62 | 110.18 | -8.02 |
ROE(%) | 3.22 | -2.32 | -5.65 | -15.47 | -14.02 | -8.07 | -27.39 | -30.43 | -8.55 | 170.23 | -12.67 |
ROCE(%) | 4.99 | -2.19 | -5.23 | -14.29 | -11.07 | -5.71 | -23.5 | -31.37 | -6.48 | 214.79 | -15.23 |
Price/Earnings(x) | 12.21 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.81 | 0 |
Price/Book(x) | 0.36 | 0.31 | 1.03 | 0.94 | 1.66 | 2.01 | 2.77 | 0.97 | 1.9 | 1.38 | 0.94 |
Dividend Yield(%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EV/Net Sales(x) | 1.67 | 1.58 | 5.26 | 2.45 | 2.31 | 2.21 | 1.7 | 0.48 | 0.67 | 1.46 | 0.49 |
EV/Core EBITDA(x) | 4.84 | -10.18 | -25.71 | -7.5 | -16.96 | -28.2 | -11.39 | -3.6 | -39.61 | -26.08 | -26.24 |
Interest Earned Growth(%) | -14.57 | -40.65 | 80.79 | 78.39 | 54.08 | 19.91 | 37.9 | 75.41 | 42.23 | 15.18 | 64.68 |
Net Profit Growth | -42.4 | -172.21 | -133.8 | -146.59 | 21.83 | 48.45 | -191 | -21.63 | 67.21 | 5161.5 | -111.5 |
EPS Growth(%) | -41.61 | -179 | -130.19 | -145.63 | 21.81 | 58.5 | -216.12 | -3.29 | 73.19 | 6126.54 | -111.52 |
Interest Coverage(x) % | 11.91 | -8.92 | -13.89 | -25.73 | -8.58 | -13.69 | -13.01 | -38.31 | -5.27 | 333.22 | -62.15 |
# | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Promoter | 73.72 | 73.72 | 73.92 | 73.92 | 73.92 | 73.92 | 73.92 | 73.92 | 73.92 | 73.92 |
FII | 0.2 | 0.52 | 0.47 | 0.4 | 0.22 | 0.32 | 0.31 | 0.32 | 0.49 | 0.56 |
DII | 0.03 | 0.05 | 0.09 | 0.09 | 0.09 | 0.09 | 0.17 | 0.17 | 0.86 | 0.96 |
Public | 26.06 | 25.71 | 25.52 | 25.6 | 25.77 | 25.67 | 25.59 | 25.59 | 24.72 | 24.56 |
Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
# | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Promoter | 2.35 | 2.35 | 2.35 | 2.35 | 2.35 | 2.35 | 2.35 | 2.35 | 2.35 | 2.35 |
FII | 0.01 | 0.02 | 0.02 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.02 | 0.02 |
DII | 0 | 0 | 0 | 0 | 0 | 0 | 0.01 | 0.01 | 0.03 | 0.03 |
Public | 0.83 | 0.82 | 0.81 | 0.81 | 0.82 | 0.82 | 0.81 | 0.81 | 0.79 | 0.78 |
Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 3.18 | 3.18 | 3.18 | 3.18 | 3.18 | 3.18 | 3.18 | 3.18 | 3.18 | 3.18 |
Pros
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Sell or Purchase Share (Tentative Price)
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
You May Also Know About